Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 38 Issue 2, February 2020

Volume 38 Issue 2

Engineering plants for vertical farms

Compact, early-fruiting ‘triple-determinate’ tomato and groundcherry plants suitable for vertical farming are produced using genome editing.

See Kwon et al.

Image: David Harris, Freight Farms, Boston. Cover Design: Erin Dewalt.

Editorial

  • Editorial |

    The US Food and Drug Administration is sticking to its plan to carry out mandatory premarket review of all gene-edited livestock, irrespective of trait risk. It should rethink.

News

Bioentrepreneur

    Building a Business

  • Building a Business |

    A detailed look at the economic impact of university-licensed life science startups across the United States reveals vast differences in the effectiveness of different regions to create ventures and sustain them as viable entities.

    • Paul C. Godfrey
    • , Gove N. Allen
    •  & David Benson

    Nature Outlook:

Correspondence

Features

    Patents

  • Patents |

    Recent patents related to lysosome-targeted therapeutics and methods of screening and visualization.

News & Views

  • News & Views |

    In a step toward nanopore sequencing of proteins, an aerolysin pore discriminates many of the proteinogenic amino acids.

    • Stefan Howorka
    •  & Zuzanna S. Siwy
  • News & Views |

    Engineering perishable crops for use in indoor farms promises to expand the adoption of this high-yielding, efficient means of food production.

    • Cathryn A. O’Sullivan
    • , C. Lynne McIntyre
    •  & Graham D. Bonnett

Research

Amendments & Corrections

Careers & Recruitment

    Career Feature

  • Career Feature |

    A quarterly snapshot of job expansions, reductions and availability in the biotech and pharma sectors.

    • Michael Francisco
  • People

  • People |

    Recent moves of note in and around the biotech and pharma industries.

Search

Quick links